---
title: MMS Holdings vs Parexel
slug_a: mmsholdings
slug_b: parexel
site: cro
review_signal_gate: closed
canonical_path: /compare/mmsholdings/parexel
generated_by: BioBM Editorial AI
---

# MMS Holdings vs Parexel

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

MMS Holdings (mmsholdings) is listed for cro. Data-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.

Services: 14. Modalities: 5. Indications: 5. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (14).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Parexel (parexel) is listed for cro. Parexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation.

Services: 17. Modalities: 3. Indications: 12. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (17).

Review summary: Review summary withheld until site-level review gate opens.